Researchers at the University of Queensland are making significant strides toward developing a groundbreaking topical cream ...
Pembrolizumab is under clinical development by Merck and currently in Phase II for Anal Cancer. According to GlobalData, Phase II drugs for Anal Cancer have a 19% phase transition success rate (PTSR) ...
Tevimbra is under clinical development by BeiGene and currently in Phase II for Soft Tissue Sarcoma. According to GlobalData, Phase II drugs for Soft Tissue Sarcoma have a 26% phase transition success ...
In May 2024, IsoPet ® was launched as a standalone division within Vivos Inc., reaffirming the company's commitment to ...
"Every cancer has a flower—my cancer is a sunflower. The sunflower is the only flower that can grow 6 feet tall. It is resilient," the mom said.